0.3048USD-4.78%Mkt Cap: —P/E: —1d ago
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Z…
Industry Peers
Health Information Services$38.07BUSDP/E 44.2
$40.77BUSDP/E 44.6
$11.74BUSDP/E 53.0
$11.05BUSD
$8.71BUSDP/E 38.9
$8.10BUSD
$7.14BUSDP/E 10.8
$4.76BUSDP/E 35.5
$4.62BUSDP/E 30.9
$3.96BUSD
$2.75BUSDP/E 97.7
$1.66BUSDP/E 43.4
$1.50BUSDP/E 36.5
$1.48BUSD
$1.28BUSD
$1.21BUSDP/E 59.0
$1.18BUSD
$870.57MUSD
$834.80MUSDP/E 39.7
$738.82MUSDP/E 74.8
Key Statistics
Company
Market Cap—
Enterprise Value182.40M $
Revenue (TTM)428.57M $
Gross Profit115.36M $
Net Income (TTM)-46.13M $
Revenue/Share3.641 USD
Last Price0.3048 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees990
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINUS0043971052
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-32.62
EV/Revenue0.43
P/S—
P/B0.94
EPS (TTM)-0.14
EPS (Forward)—
52W Range
0.30403% of range0.3271
52W High0.3271 USD
52W Low0.3040 USD
Profitability
Gross Margin26.92%
Oper. Margin-2.43%
EBITDA Margin-1.30%
Profit Margin-10.76%
ROE-101.06%
ROA-1.65%
Growth
Revenue Growth-7.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.12M $
CapEx (TTM)—
FCF Margin-2.54%
FCF Yield—
Net Debt144.33M $
Net Debt/EBITDA-25.81
Balance Sheet
Debt/Equity437.33
Current Ratio1.42
Quick Ratio0.58
Book Value/Sh0.3510 USD
Cash/Share0.3200 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.86.66M
Float113.00M
Insiders4.34%
Institutions64.48%
Technical
SMA 502.728 (-88.8%)
SMA 2003.149 (-90.3%)
Beta1.39
S&P 52W Chg20.80%
Avg Vol (30d)10.18K
Avg Vol (10d)884
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—